| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stroke, Vol 15, 40-45, Copyright © 1984 by American Heart Association
TC Hill, PL Magistretti, BL Holman, RG Lee, DH O'Leary, RF Uren, HD Royal, CI Mayman, GM Kolodny and ME Clouse
In this study we assessed regional cerebral blood flow in patients with
signs and symptoms of acute stroke using single-photon emission computed
tomography (SPECT) and N-isopropyl I-123 p-iodoamphetamine (IMP).
Twenty-five patients with acute cerebral infarction had both IMP brain
perfusion studies and CT scans performed within one week of each other; 22
had positive and three had negative perfusion studies. Of the 22 patients
who had positive perfusion studies, six had negative CT studies initially.
In the 16 patients who had abnormal CT studies, eight of the studies
depicted areas of edema that were smaller than the perfusion deficits noted
on the IMP studies and eight had areas of edema that were approximately
equal in size to the perfusion defect. Of the three patients with normal
IMP studies, two had normal CT studies and one had a positive CT study
showing a 3-mm lacunar infarction. Using eight control patients, mean count
rates per tissue volume normalized for the injected dose was calculated.
Similarly, the quantitative data from regions of interest in the stroke
patients were calculated and compared to the control patients or to a
normal region in the uninvolved hemisphere in the same patients. SPECT with
IMP was used to assess regional brain perfusion in acute cerebral
infarction. Perfusion abnormalities were seen in our patients when the CT
scan was normal, and quantitative data could be used to approximate
regional cerebral blood flow in these patients when compared to the normal
patient population.
ARTICLES
Assessment of regional cerebral blood flow (rCBF) in stroke using SPECT and N-isopropyl-(I-123)-p-iodoamphetamine (IMP)
This article has been cited by other articles:
![]() |
A.E. Baird, M.C. Austin, W.J. McKay, G.A. Donnan, and G.A. Donnan Sensitivity and Specificity of 99mTc-HMPAO SPECT Cerebral Perfusion Measurements During the First 48 Hours for the Localization of Cerebral Infarction Stroke, May 1, 1997; 28(5): 976 - 980. [Abstract] [Full Text] |
||||
![]() |
B. L. Holman and S. S. Tumeh Single-Photon Emission Computed Tomography (SPECT) Applications and Potential JAMA, January 26, 1990; 263(4): 561 - 564. [Abstract] [PDF] |
||||
![]() |
M. Rango, L. Candelise, D. Perani, C. Messa, G. Scarlato, N. Canal, M. Franceschi, and F. Fazio Cortical Pathophysiology and Clinical Neurologic Abnormalities in Acute Cerebral Ischemia: A Serial Study With Single Photon Emission Computed Tomography Arch Neurol, December 1, 1989; 46(12): 1318 - 1322. [Abstract] [PDF] |
||||
![]() |
B. I. Lee, O. N. Markand, H. N. Wellman, A. R. Siddiqui, H. M. Park, B. Mock, R. M. Worth, M. K. Edwards, and J. Krepshaw HIPDM-SPECT in Patients With Medically Intractable Complex Partial Seizures: Ictal Study Arch Neurol, April 1, 1988; 45(4): 397 - 402. [Abstract] [PDF] |
||||
![]() |
H. H. Harsch, R. S. Tikofsky, and B. D. Collier Single Photon Emission Computed Tomography Imaging in Vascular Stroke Arch Neurol, April 1, 1988; 45(4): 375 - 376. [Abstract] [PDF] |
||||
![]() |
G. Defer, J.-L. Moretti, P. Cesaro, A. Sergent, C. Raynaud, and J.-D. Degos Early and Delayed SPECT Using N-Isopropyl p-Iodoamphetamine Iodine 123 in Cerebral Ischemia: A Prognostic Index for Clinical Recovery Arch Neurol, July 1, 1987; 44(7): 715 - 718. [Abstract] [PDF] |
||||
![]() |
B. L. Holman, T. C. Hill, J. F. Polak, R. G. L. Lee, H. D. Royal, and D. H. O'Leary Cerebral Perfusion Imaging With Iodine 123-Labeled Amines Arch Neurol, October 1, 1984; 41(10): 1060 - 1063. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |